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Abstract: Hypnale hypnale (hump-nosed pit viper) has been recently identified as one of the medically 
important venomous snakes in Sri Lanka and on the southwestern coast of India. The characterization 
of its venom is essential for understanding the pathophysiology of envenomation and for optimizing 
its management. In the present study, the biological properties of Hypnale hypnale venom and venom 
fractions obtained using Resource Q ion exchange chromatography were determined. The venom 
exhibited toxic activities typical of pit viper venom, comparable to that of its sister taxon, the Malayan pit 
viper (Calloselasma rhodostoma). Particularly noteworthy were its high activities of thrombin-like enzyme, 
proteases, phospholipase A2, L-amino acid oxidase and hyaluronidase. The thrombin-like enzyme was 
mainly acidic and distributed over several chromatography fractions, indicating its existence in multiple 
isoforms. The hemorrhagic and necrotic activities of the venom were likely associated with the proteolytic 
enzyme found mainly in the basic fraction. Phospholipase A2 and phosphomonoesterase exist in both acidic 
and basic isoforms, while L-amino acid oxidase and hyaluronidase are highly acidic. The venom clotting 
activity on fibrinogens showed distinct species specificity in the following increasing order for clotting time: 
bovine < rabbit < goat < human < horse < < dog, and was comparable to that of C. rhodostoma venom. Its 
clot formation on human fibrinogen is gradual and prolonged, a phenomenon suggestive of consumptive 
coagulopathy as a complication observed clinically. At an intramuscular sublethal dose, the venom did not 
cause acute kidney injury in a rodent model, contrary to the positive control group treated with Daboia 
russelii venom. Nephrotoxicity may result from higher venom doses in the context of coagulopathy, as a 
complication provoked by venom hematoxicity.
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INTRODUCTION
Snakes from the Viperidae family, including 
both vipers (viperines) and pit vipers (crotalids), 
are known to produce venoms that are principally 
hematoxic (1, 2). These venoms generally contain 
well over one hundred protein constituents, of 
which toxins belong to only a few major protein 
families that include such enzymes as serine 
proteases, Zn2+-metalloproteases, L-amino 
acid oxidase and group II PLA2; as well as non-
enzymatic proteins (constituting a smaller 
portion) including disintegrins, C-type lectins, 
myotoxins, cysteine-rich secretory protein 
(CRISP) toxins etc. (3, 4). This context reflects 
the emergence of toxins from a restricted set 
of physiological protein families recruited 
into the venom proteome at the base of the 
Colubroidea radiation, ideal for their primary 
role in predation and defense (5, 6). Nevertheless, 
envenomation of humans causes serious public 
health problems, for which it has been duly 
categorized as a “disease” according to the WHO 
International Classification of Disease (ICD-10), 
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and appropriately categorized as a Neglected 
Tropical Disease (7). This problem also affects 
most tropical and subtropical countries, many 
of which are still underdeveloped, hence its apt 
description as a disease of poverty (8). Despite 
this, the envenomation issue remains systemically 
neglected in many parts of the world (9). 
In South Asia, annual mortality due to 
snakebites has been estimated to be 1,000 in 
Sri Lanka and 20,000 in India (10). Hypnale 
hypnale (hump-nosed pit viper) has been recently 
recognized as a medically important venomous 
snake in Sri Lanka and on the southwestern coast 
of India (11, 12). It is now listed as a category I 
snake of medical importance by the World Health 
Organization, owing to its wide distribution and 
high prevalence of bites which cause significant 
morbidity and mortality in the region (13). This 
snake is mainly nocturnal and both arboreal and 
terrestrial. It inhabits both wet and dry deciduous 
zones; can be found in settings ranging from 
secondary forests, hilly areas, various plantations 
to low land gardens and even latrines within home 
compounds. Being well camouflaged and tiny in 
size (body length rarely exceeds 0.5 m), it is easily 
missed and trodden upon even in the daytime, 
resulting in its defensive bite (11). In Sri Lanka, 
it is not uncommon to come across H. hypnale 
envenoming even in the capital city of Colombo, 
although more cases occur in the suburban and 
rural areas. 
Although the local effects of its bites were well 
observed and documented, it remains controversial 
after more than a century as to whether H. 
hypnale bites could be fatal (14-18). Recent 
clinical studies indicated that envenomation 
by this snake resulted in local edema, necrosis, 
regional lymphadenopathy, as well as systemic 
effects characterized by hemostatic dysfunction 
(coagulopathy, fibrinolysis, thrombocytopenia, 
spontaneous systemic hemorrhage) and acute 
renal failure, with an overall fatality rate of 1.7% in 
authenticated cases (11, 12, 19-22). To date, apart 
from the Calloselasma rhodostoma antivenoms 
(produced by the Thai Red Cross Society) which 
were shown to confer paraspecific neutralization 
in rodent models, there is no specific antivenom 
that is clinically effective against the H. hypnale 
venom (11, 12, 23). 
In order to address the envenoming issue 
holistically, the venom’s toxinological profile 
should be studied to elucidate its pathogenesis. In 
this paper, we report the biological properties of 
the venom and its ion exchange chromatography-
fractionated components, using in vitro and/or 
in vivo methods. Its clotting activity on several 
mammalian fibrinogens was also investigated. A 
rodent model was also used to study the in vivo 
nephrotoxic effects of this venom. 
MATERIALS
Venoms
Hypnale hypnale venom was a pooled sample 
obtained from the milking of adult snakes captured 
in Sri Lanka (Gamapha, Kelaniya, Avissawela, 
Colombo regions). The snakes were kept at the 
snake farm in the University of Colombo, Sri 
Lanka and were identified by Anslem de Silva, 
an expert herpetologist. Venoms of Calloselasma 
rhodostoma, Cryptelytrops purpureomaculatus 
and Daboia russelii (Myanmar) were purchased 
from Latoxan (Valence, France).
Reagents and Animals
All reagents and chemicals were purchased 
from Sigma Chemical Company (USA) and were 
of analytical grade. Albino mice (ICR strain) 
and Sprague Dawley rats were supplied by the 
Laboratory Animal Center, Faculty of Medicine, 
University of Malaya. The use of animals was 
approved by the institute and these animals were 
handled according to the guidelines of the Council 
for International Organizations of Medical Sciences 
(CIOMS) on animal experimentation (24). 
METHODS
Fractionation of H. hypnale venom by 
Resource® Q Ion-Exchange Chromatography 
Five milligrams of the venom dissolved in 200 
µL of starting buffer (20 mM Tris-HCl, pH 8.5) 
was filtered through a 0.2 µm pore size syringe 
filter. The filtrate was then injected into Resource® 
Q ion-exchange column  (GE Healthcare, USA) 
(6.4 mm x 30 mm, 1 mL gel volume, 15 µm particle 
size, 200-10,000 Å) pre-equilibrated with starting 
buffer, and subsequently eluted by a linear, 0.0 to 
0.5 M sodium chloride gradient (0-30% from 5 
to 30 minutes, followed by 30-100% from 30 to 
55 minutes), at the flow rate of 1 mLmin–1. The 
solvent delivery and gradient formation over 60 
minutes was achieved by using the Shimadzu LC-
20AD® high performance liquid chromatography 
Tan CH, et al. Toxinology of H. hypnale venom and its HPLC fractions
J Venom Anim Toxins incl Trop Dis  |  2011  |  volume 17  |  issue 4 475
(HPLC) system (Japan). Protein peaks were 
monitored by measuring the absorbance at 280 
nm. The protein content of the fractions was 
determined by the Bradford method (25).
Determination of Enzymatic Activities
This portion of the study was done on 
the venoms of H. hypnale and Calloselasma 
rhodostoma for comparison, as well as on the 
HPLC-isolated protein fractions of H. hypnale 
venom. Two independent experiments were 
carried out on each test for each sample, and the 
average results were reported.
Protease assay
Protease activity was measured by 
modification of the method described by Kunitz 
(26). One milliliter of 1% casein in 0.25 M sodium 
phosphate buffer, pH 7.75, and 50 μL of sample 
solution were incubated for 30 minutes at 37°C. 
The reaction was terminated by adding 1 mL of 
5% trichloroacetic acid. After centrifugation at 
10,000 x g for ten minutes, the absorbance of the 
supernatant was measured at 280 nm. One unit of 
protease activity was defined as an increase of one 
absorbance unit per hour at 280 nm. 
Phospholipase A2 assay
Phospholipase A2 activity was determined 
by the acidimetric method (27). The egg yolk 
substrate suspension was prepared by mixing one 
part chicken egg yolk, one part 18 mM calcium 
(II) chloride, and one part 8.1 mM sodium 
deoxycholate. The pH of the substrate suspension 
was adjusted to 8.0 with 1 M sodium hydroxide. 
The suspension was stirred to ensure good mixing. 
One hundred microliters of venom solution was 
added to 15 mL of the substrate suspension and 
the rate of decrease in pH was recorded using a 
pH meter. A decrease of 1 pH unit of the egg yolk 
suspension corresponded to 133 μmol of fatty 
acids released.
Arginine ester hydrolase assay
Arginine ester hydrolase was assayed using 
α-benzoyl arginine ethyl ester as substrate (28). 
The assay mixture contained 0.95 mL of 0.8 mM 
substrate in 0.05 M Tris-HCl buffer, pH 7.8, 
and 50 μL of sample solution. The reaction was 
monitored by measuring the rate of increase 
in absorbance at 255 nm. The difference in the 
extinction coefficient at 255 nm is 815 cm–1M–1.
Phosphodiesterase assay
Phosphodiesterase activity was determined 
by a method modified from Lo et al. (29). One 
hundred microliters of sample was added to 
an assay mixture containing 0.5 mL of 2.5 mM 
calcium bis-p-nitrophenylphosphate, 0.3 mL of 
0.01 M magnesium sulfate and 0.5 mL of 0.17 
M veronal buffer, pH 9.0. The hydrolysis of the 
substrate was monitored by measuring the rate of 
increase of absorbance at 400 nm. The extinction 
coefficient is 8100 cm–1M–1.
Alkaline phosphomonoesterase assay
Alkaline phosphomonoesterase activity was 
determined by a method modified from Lo et 
al. (29). One hundred microliters of sample was 
added to an assay mixture containing 0.5 mL of 
0.5 M glycine buffer (pH 8.5), 0.5 mL of 10 mM 
p-nitrophenylphosphate and 0.3 mL of 0.01 M 
magnesium sulfate. The mixture was incubated at 
37°C for 30 minutes. At the end of the incubation 
period, 2 mL of 0.2 M sodium hydroxide was 
added and allowed to stand for 20 minutes at 
room temperature. The absorbance at 400 nm 
was then measured. The extinction coefficient is 
18500 cm–1M–1.
5’-Nucleotidase assay
5’-Nucleotidase activity was determined 
using 5’-AMP as substrate (30). One hundred 
microliters of sample was added to an assay 
mixture containing 0.5 mL of 0.02 M 5’-AMP 
(preadjusted to pH 8.5), 0.5 mL of 0.2 M glycine 
buffer, pH 8.5, and 0.1 mL of 0.1 M magnesium 
sulfate. The mixture was incubated for ten minutes 
at 37°C, and the reaction was terminated by the 
addition of 1.5 mL of 10% trichloroacetic acid. 
The ascorbic acid method was used to determine 
the inorganic phosphate content (31). To the 
above mixture, 1 mL of ascorbic acid reagent – 
containing equal parts of 3 M sulfuric acid, 2.5% 
ammonium molybdate, 10% ascorbic acid and 
water – was added. The mixture was left at room 
temperature for 30 minutes, and the absorbance 
at 820 nm was then measured. A standard curve 
was constructed using known concentrations of 
inorganic phosphate.
Hyaluronidase assay
Hyaluronidase activity was determined 
turbidimetrically (32). The assay mixture 
contained 0.45 mL of 0.2 M acetate buffer, pH 5.0, 
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containing 0.15 M sodium chloride and 0.2 mg 
of human umbilical cord hyaluronic acid and 50 
μL of sample solution. The mixture was incubated 
for 1 h at 37°C. The reaction was terminated by 
the addition of 1 mL of 2.5% cetyltrimethyl-
ammonium bromide in 2% sodium hydroxide 
solution. After 30 minutes, the absorbance at 
400 nm was measured. Enzymatic activity was 
expressed as NFU/mg (National Formulary 
Units). Appropriate dilutions of sample were 
performed to ensure that the difference in 
absorbance between the blank and sample was 
less than 0.4. Hyaluronidase (EC 3.2.1.35), 
originating from bovine testes, was purchased 
from Sigma Chemical Co. (USA) and used as a 
standard; its activity is 270 NFU per mg. Several 
dilutions of hyaluronidase representing a series of 
NFUs were tested on solution containing 0.2 mg 
of hyaluronic acid. The absorbance values were 
plotted against the NFUs for calibration. 
L-amino acid oxidase
L-amino acid oxidase activity was determined 
as described by Tan et al. (33). Fifty microliters of 
horseradish peroxidase (100 purpurogalin unit/
mg) was added to 0.9 mL of 0.2 M triethanolamine 
buffer, pH 7.6, containing 0.1% L-leucine and 
0.0075% o-dianidisine and incubated for three 
minutes at room temperature. Sample solution 
(50 μL) was then added and the increase in 
absorbance at 436 nm was measured. The molar 
absorption coefficient is 8.31 x 103 cm–1M–1.
Determination of Lethality, Hemorrhagic, 
Procoagulant and Necrotic Activities
Median lethal dose (LD50)
The LD50 values of H. hypnale venom were 
determined by intraperitoneal injection of the 
venom into mice (18-22 g, n = 4 per dose) whose 
survival ratio was recorded after 48 hours. The 
intraperitoneal LD50 (and the 95% confidence 
intervals, CI) of the venom was calculated using 
the Probit analysis method of Finney (34). The 
intramuscular LD50 value of H. hypnale was 
based on a previous determination from the 
same laboratory as reported by Tan et al. (23), 
while that for D. russelii was determined via 
intramuscular injection of the venom into hind 
legs of mice (n = 4 per dose), and analyzed as 
previously mentioned.
Hemorrhagic activity 
Hemorrhagic activity was determined 
according to Theakston and Reid (35) with 
modifications. The venom dissolved in phosphate-
buffered saline (50 μg in 50 μL) or the venom 
fraction (50 μL) was injected intradermally into 
the shaved dorsal skin of lightly anesthetized mice. 
After 90 minutes, the animals were euthanized 
with an overdose of diethyl ether. The dorsal skin 
was removed carefully, and the mean diameter of 
the hemorrhagic lesion on the inner surface of 
the skin was measured. 
Procoagulant activity
Procoagulant activity was determined by the 
method described by Bogarin et al. (36). The 
venom (50 µg in 0.1 mL) or venom fraction (0.1 
mL) was added to 0.2 mL of bovine fibrinogen 
solution (2 g/L) at 37°C. The coagulation time 
(time required for fibrin strands to form) was 
recorded. A shorter coagulation time suggests 
higher procoagulant activity.
Necrotic activity
Necrotic activity was determined by a modified 
version of the method of Theakston and Reid (35). 
The venom, (50 μg in 50 μL) or venom fraction 
(50 µL) was injected intradermally into the 
shaved dorsal skin of lightly anesthetized mice. 
After 72 hours, the animals were euthanized with 
an overdose of diethyl ether, the dorsal skin was 
removed, and the mean diameter of the necrotic 
lesion was measured. 
Fibrinogen clotting activity 
The fibrinogen clotting activity (procoagulant 
effect) of H. hypnale venom was tested further 
on fibrinogens from several mammalian sources. 
Venoms from two other Asiatic pit vipers, C. 
rhodostoma and C. purpureomaculatus, well 
known for their procoagulant effects, were 
studied simultaneously for comparison (37, 38).
The venom (50 µg in 0.1 mL) was added to 0.2 
mL of fibrinogen solution from various animal 
sources (2 g/L) at 37°C. The coagulation time (time 
elapsed for fibrin strands to form) was recorded. To 
study the time course of venomous procoagulant 
activities, each venom (50 µg in 0.1 mL) was added to 
0.2 mL of fibrinogen solution (2 g/L) preincubated 
at 37°C. The absorbance of the mixture at 450 nm 
was read for ten minutes to monitor the formation 
and degradation of fibrin clots.
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Nephrotoxicity study
Sprague dawley rats were divided into three 
groups of three animals each: normal saline 
(NS) group, H. hypnale venom (HV) group 
and Daboia russelii venom (DV) group. The NS 
group and DV groups represented, respectively, 
the negative and positive controls. Rats from 
each group received intramuscular injections of 
treatment as follows: 200 µL of normal saline, or 
200 µL of venom solution corresponding to one 
third of the venom’s intramuscular LD50. The rats 
were kept for 24 hours in metabolic cages with 
access to feed and water ad libitum. Urine was 
collected throughout 24 hours, while blood was 
collected via cardiac puncture under anesthesia at 
the end of experiment. The urine and blood were 
sent for biochemical analysis, to an outsourced 
service at a pathology analytical laboratory. Major 
organs harvested from rats upon death following 
cardiac punctures were sent for histopathological 
studies. Specimens were fixed in 10% formalin, 
followed by paraffin wax-embedding, sectioning 
of tissue, dewaxing, rehydration, and staining 
with hematoxylin and eosin. The sections were 
cover-slipped and images were captured using a 
Nikon Research Trinocular Teaching Microscope 
Eclipse 80i® (Japan) equipped with a camera. 
Statistical analysis
The variability of lethality assays was 
expressed within 95% confidence intervals (CI). 
The significance of the differences of the means 
was determined by two-tailed unpaired Student’s 
t-test or one-way ANOVA. Statistical analyses 
were carried out using the statistical software 
SPSS. 
RESULTS AND DISCUSSION
Milking of Snake Venom
In an investigation of venom yield, the milking 
of six adult H. hypnale snakes yielded 10.0 mg, 
8.7 mg, 11.4 mg, 20.0 mg, 12.2 mg and 15.6 mg, 
respectively, of dried venom. The average amount 
of venom obtained per milking is therefore 13 
mg (± 4.2 mg). Hence the maximum amount of 
venom injected per bite is expected to be less than 
20 mg, much lower than the roughly 50 mg per 
yield reported in its sister taxon, C. rhodostoma 
(37). This is predictable as the body size of H. 
hypnale is small and rarely grows beyond 0.5 m.
Lethality of the Venom
H. hypnale venom has an intraperitoneal 
median lethal dose (LD50) of 6.0 µg/g (95% CI 
4.2-8.1 µg/g) of mouse body weight, which is 
intermediate between the intravenous LD50 (0.9 
µg/g) and the intramuscular LD50 (13.7 µg/g) 
reported by our research group in an earlier 
study (23). This suggests that the potency 
of toxins causing lethality differs depending 
on the administration route. A much lower 
intravenous LD50 indicates that the venom is 
likely to be principally hematoxic in action, 
while the intraperitoneal LD50 is higher than 
the intravenous value possibly due to delayed 
an/or incomplete absorption (as in first pass 
phenomenon) of the toxins before reaching the 
systemic circulation (39, 40). The fact that the 
intraperitoneal LD50 value is lower than that of 
the intramuscular route is likely due to higher 
bioavailability given that more venom is quickly 
absorbed intraperitoneally (larger surface area 
and richer blood supplies) without having to bind 
and interact with muscle and connective tissues. 
The median intramuscular lethal dose of D. 
russelii venom tested in mice was 0.70 µg/g (95% 
CI, 0.45-0.9 µg/g) of body weight, which was 
determined for use in the nephrotoxicity study.
Biological Properties of H. hypnale and C. 
rhodostoma Venoms
The H. hypnale venom used in this study showed 
higher activities of proteases, phospholipase A2, 
L-amino acid oxidase and hyaluronidase than 
those found in a previous report (41) (Table 1). 
This may be due to ontogenic differences as the 
venom used in this study was a recently pooled 
sample. The procoagulant activity, however, did 
not differ markedly between the two reports. 
H. hypnale venom exhibited enzymatic 
properties similar to C. rhodostoma venom 
(Table 1), which are quite typical of pit viper 
venoms, notably the presence of arginine 
ester hydrolase and potent protease activities. 
Particularly noteworthy is the substantially 
higher phospholipase A2 activity in H. hypnale 
venom; in comparison, C. rhodostoma venom 
usually exhibits rather / very low phospholipase 
A2 activity. Phospholipases A2 are known to 
exhibit multiple pharmacological activities, 
including lipid membrane damage, myotoxicity 
and myonecrosis (42, 43). High amounts of 
phospholipase A2, proteases and L-amino acid 
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oxidase, known for their cytotoxic and tissue-
damaging properties, are likely responsible for the 
local envenoming features, e.g. edema, necrosis 
and hemorrhagic blistering commonly seen after 
H. hypnale bites (11, 12, 43-45). In addition, 
hyaluronidase that presents substantially in the 
venom can synergistically potentiate the venom 
propagation and its local effects, contributing to 
severe local tissue destruction (46).
H. hypnale venom also showed potent 
procoagulant or thrombin-like enzyme activities 
(lower than that of C. rhodostoma), as well as 
hemorrhagic and necrotic properties (higher 
than or similar to that of C. rhodostoma). These 
activities are hallmark of the pathophysiology 
induced by pit viper venoms. The general 
similarities in the biological activities of H. hypnale 
venom and C. rhodostoma venom are expected as 
they are closely related phylogenetically, hence 
the possibility of sharing similar venom antigens 
(47, 48). 
Fractionation of H. hypnale venom 
by Resource® Q Anion Exchange 
Chromatography 
Ion exchange chromatography separates 
proteins based on their ionic charges, and has been 
useful in snake venom fractionations as it does 
not affect the biological activity of eluted proteins, 
hence allowing their characterizations (33, 38). 
With Resouce® Q column, an anion exchanger, H. 
hypnale venom was fractionated yielding twelve 
major fractions (Figure 1). Protein estimation by 
the Bradford method (25) showed that fraction 
12 has very little protein content. Fractions 1 
and 2 are unbound fractions and contain basic 
proteins, while the remaining fractions generally 
contain proteins of an increasingly acidic nature. 
Biochemical Properties of the Protein 
Fractions of H. hypnale venom 
Table 2 shows the biological properties of 
the 12 fractions obtained from Resource® Q 
chromatography of H. hypnale venom. Fraction 
1, containing the basic proteins, was certainly 
heterogeneous, as it possessed multiple enzyme 
activities including proteases, phospholipase 
A2, alkaline phosphomonoesterase, 
phosphodiesterase and 5’-nucleotidase activities. 
It was also the only fraction that exhibited 
hemorrhagic and necrotic activities, and both 
of these toxic effects were likely associated with 
the proteolytic activity, as reported in viperid 
metalloproteinases (1). Both fractions 1 and 3 
exhibited phospholipase A2 activity, suggesting 
that the venom contains at least two forms of 
phospholipase A2. This finding is in accord with 
a previous report (49) where only two out of four 
PLA2 isoforms isolated from H. hypnale venom, 
using combined gel filtration and reversed-phase 
chromatography, exhibited enzymatic activities. 
We suggest that these two reported enzymes 
belong to a basic form (fraction 1) and an acidic 
form (fraction 3), respectively. 
Hydrolytic enzymes – such as 
phosphodiesterase (a nuclease), 5’-nucleotidase 
Table 1. Enzymatic, hemorrhagic and necrotic activities of H. hypnale and C. rhodostoma venoms
Activity
Species
PRO PLA2 LAO AEH PME PDE 5’-Nuc HYA TLE HEM NEC
H. hypnale# 15.8 191.5 191.7 10.05 4.8 4.1 1.8 115.5 20 23 7.5
C. rhodostoma# 18.5 79.8 165.4 8.96 4.6 18.5 1.9 76.6 10 16 8.0
H. hypnale@ 7.8 126 110 15.2 12 6 2.7 85 22 1.6* ND
PRO: protease, unit/mg; PLA2: phosphopholipase A2, µmol/min/mg; LAO: L-amino acid oxidase, nmol/min/mg; AEH: arginine ester 
hydrolase, µmol/min/mg; PME: alkaline phosphomonoesterase, nmol/min/mg; PDE: phosphodiesterase, nmol/min/mg; 5’-Nuc: 
5’-nucleotidase, µmol/min/mg; HYA: hyaluronidase, NFU/mg; TLE: thrombin-like enzyme (procoagulant enzyme), s/50 µg venom; 
Hem: hemorrhagin, mm/50 µg venom; NEC: necrosis, mm/50 µg venom; ND: not determined. Values were the average results from 
two independent experiments. 
# Present study; @ reference to Tan and Ponnudurai (41); * the unit was expressed as the product of two perpendicular diameters of 
the lesion, which is different from the unit defined in the present study. 
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and alkaline phosphomonoesterase – are 
high molecular weight proteins known to be 
widely distributed across many snake taxa, but 
their toxic effects have been less extensively 
characterized partly due to the fact that these 
enzymes share similar substrates and biochemical 
properties (50). In general, our results showed 
that all three enzymes were found in H. hypnale 
venom in appreciable amounts, particularly 
phosphodiesterase, which is usually abundant 
in crotalid venoms. Phosphodiesterase had been 
associated with a drop in mean arterial pressure 
and locomotor depression, presumably due to 
reduced cAMP levels (51). This feature, however, 
has not been reported in systemic envenomation 
by H. hypnale, implying that its function might 
be more digestive than purely toxinological. 
The chromatography result also showed that 
5’-nucleotidase and phosphomonoesterase from 
H. hypnale venom exist in both basic and acidic 
isoforms. It is intriguing to note the existence 
of acidic phosphomonoesterase in this venom, 
as this enzyme, contrary to the basic/alkaline 
phosphomonoesterase, has so far only been 
purified from sea snake venoms and rarely been 
reported in other snake venoms (52). 
Thrombin-like activity was found to be 
widespread from fraction 2 to fraction 8, 
indicating that the enzyme likely existed in 
multiple isoforms. The two fractions (fraction 
5, 6) with the strongest thrombin-like activity 
were also the two fractions that hydrolyzed 
arginine esters, suggesting that the thrombin-
like enzymes exhibited arginine ester hydrolase 
activity, a property similar to that of ICR-50 
arvin, a coagulant enzyme derived from C. 
rhodostoma venom (28). The enzyme esterolytic 
activity towards N-α-benzoyl-l-arginine ethyl 
ester indicated its specific binding to the arginine 
residues in its substrate. The venom also contained 
one or more forms of L-amino acid oxidase which 
appeared more acidic than many other enzymes, 
and its activity was noted to be lost by freezing. 
Such freeze-labile activity had been reported and 
the mechanism is presumably due to a limited 
conformational change of the enzyme structure 
(53, 54). Fraction 12, which contained few 
proteins, was found to be devoid of enzymatic 
activities. As demonstrated, venom fractionation 
helps elucidate the different components in 
venoms allowing their toxic characterizations for 
pathophysiological correlations. Nonetheless, it 
also opens the door to manipulating specific toxins 
in search of potential therapeutic compounds, as 
already observed in drug discoveries of ancrod, 
captopril etc. (55). 
Figure 1. Fractionation of Hypnale hypnale venom with Resource® Q anion exchange chromatography. The 
venom (5 mg) was injected into the column equilibrated with 20 mM Tris-HCl, pH 8.5, and eluted by a linear, 
0.0 to 0.5 M NaCl gradient (0-30% from 5 to 30 minutes, followed by 30-100% from 30 to 55 minutes. Flow 
rate was 1 mL/min. (-----): NaCl concentration gradient (%)
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Fibrinogen Clotting Activity 
The clotting activity of H. hypnale venom 
showed distinct species differences (Table 3). 
The clotting time of mammalian fibrinogens by 
H. hypnale venom was in the increasing order as 
follows: bovine < rabbit < goat < human < horse 
< < dog. The clotting activity of C. rhodostoma 
venom exhibited a similar pattern (most and least 
active towards the bovine and dog, respectively) 
indicating that the thrombin-like activity of the 
venoms of these two phylogenetically related 
crotalids exhibited similar specificity towards 
fibrinogens. On the other hand, the specificity 
of the clotting activity of C. purpureomaculatus 
venom (bovine < goat < human < horse < < 
rabbit, dog) was rather different, and generally 
showed a lower clotting potency for bovine, goat 
and human fibrinogens (p < 0.05). 
The clotting activities of the three venoms 
were also monitored spectrophotometrically 
whereby the turbidity of the reaction mixture was 
continuously monitored for absorbance at 450 
nm. The investigation of the time course of clot 
assembly had also been described by Pirkle et al. 
(56). Generally, the appearance of fibrin or clots 
would result in turbidity, while degradation of the 
clots would reduce this property. Figure 2 (A to 
D) shows that both H. hypnale and C. rhodostoma 
venoms caused rapid clotting with fibrinogens 
from bovine, goat, horse and rabbit specimens. 
Dissolution of clots was rapid in the case of goat 
(Figure 2 – B) and horse fibrinogens (Figure 2 
– C) (turbidity reduced from 30 seconds). Both 
venoms were active in the clotting of human 
fibrinogen (Figure 2 – E), showing a slow but 
prolonged clotting effect. C. purpureomaculatus 
venom generally demonstrated moderate to 
low clotting activities, except for the case of dog 
fibrinogen (Figure 2– F) where it appeared more 
active than the venoms of H. hypnale and C. 
rhodostoma. 
We suggest that a rapid clotting profile implies 
the possibility that the venom may precipitate 
acute thrombotic syndrome that can be instantly 
Table 2. Enzymatic, hemorrhagic and necrotic   activities  of major  protein fractions  of H. hypnale 
venom obtained from Resource Q ion-exchange chromatography
Test
Fraction
AMT PRO PLA2 LAO AEH PME PDE 5’-Nuc HYA TLE HEM NEC
1 240 8.3 79.8 – – 0.5 9.8 0.18 – – 9 6
2 59 – – – – – – – – 470 – –
3 77 – 159.6 – – – – – – 212 – –
4 32 – – – – – – 0.15 – 115 – –
5 47 – – – 9.8 – – 0.30 – 84 – –
6 58 – – – 2.5 – – 0.66 – 77 – –
7 28 – – – – – – – – 146 – –
8 18 – – – – 1.7 – – – 610 – –
9 12 – – 13.8 – 0.9 – – 6.9 – – –
10 41 – – 11.3 – 0.1 – – 46.9 – – –
11 10 – – – – – – – 6.6 – – –
12 4 – – – – – – – – – – –
AMT: Total protein amount recovered in each respective fraction, µg; PRO: protease, unit/mL; PLA2: phosphopholipase 
A2, µmol/min/mL; LAO: L-amino acid oxidase, nmol/min/mL; AEH: arginine ester hydrolase, µmol/min/mL; PME: alkaline 
phosphomonoesterase, nmol/min/mL; PDE: phosphodiesterase, nmol/min/mL; 5’-Nuc: 5’-nucleotidase, µmol/min/
mL; HYA: hyaluronidase, NFU/mL; TLE: thrombin-like enzyme (procoagulant enzyme), s/100 µL; HEM: hemorrhagic 
activity, mm/50 µL; NEC: necrotic activity, mm/50 µL, –: absent activity. Values were the average results from two 
independent experiments.
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fatal, as observed in an experiment where a 
rabbit was injected with H. hypnale venom 
intravenously (unpublished data). In cases where 
clot formation is less rapid, or is accompanied by 
a concurrent degradation, the most likely cause of 
death would be a consumptive coagulopathy that 
gradually affects hemostasis, causing prolonged 
bleeding and a “slower” death. This is consistent 
with main clinical features reported in cases of 
envenomation by C. rhodostoma (57, 58) and H. 
hypnale (11, 12). Deranged hemostasis leading to 
systemic bleeding has been the main feature in 
systemic envenomation by these crotalids. This 
severe, potentially fatal complication might only 
manifest itself temporarily following the bite as 
the pre-existing coagulant factors get depleted or 
rendered inactive by the venom more rapidly than 
their production, hence tilting the hemostatic 
balance towards a tendency to bleed. A recent 
example was that of an extensive retroperitoneal 
hemorrhage only detected five weeks after a bite 
by H. hypnale in an adult patient (59).
Nephrotoxicity Study
Ariaratnam et al. (11) reported a series of 302 
hump-nosed pit viper bites in which 117 (39%) 
were systematically envenomed, all with hemostatic 
abnormalities, while 30 presented with acute renal 
failure. The kidney, as a highly vascularized excretory 
organ, is certainly vulnerable to acute injury by 
venom toxicity. The injury mechanisms can be 
either by direct effect of the toxins or secondary 
to hemostatic defect, intravascular hemolysis, 
shock, immune response or rhabdomyolysis. 
Hematoxic and myotoxic venoms from viperids or 
crotalids are a rich source of enzymes that include 
phospholipases, endopeptidases, L-amino acid 
oxidases and metalloproteases which can directly 
cause cellular damage and kidney injury (60, 61). In 
the present study, D. russellii venom from Myanmar 
was administered to the positive control group (DV 
group) to produce acute kidney injury as the venom 
was known to be highly nephrotoxic (62-65).
Rats from both HV and DV groups treated 
with a sublethal dose (1/3 LD50) of venoms of 
H. hypnale and D. russelii respectively, exhibited 
envenomation signs e.g. local hemorrhage, 
malaise, drowsiness and limping in the first 
few hours. All animals survived the 24-hour 
observation period. Gross inspection of urines 
showed marked hematuria among the DV group, 
with no inter-group difference in the urine 
volumes. Biochemical and microscopic urinalysis 
revealed significant proteinuria and hematuria in 
the DV group compared to the HV and NS groups 
(p < 0.05) (Table 4). The urea and creatinine 
levels, used as indicators for acute renal failure, 
were observably higher in the DV group although 
this elevation was insignificant in relation to the 
other two groups (Table 4), a finding probably 
attributable to the fact that the observation 
period was not sufficiently long. Nevertheless, 
the significant proteinuria and hematuria are 
sufficient indication that the injected D. russelii 
venom did cause acute nephrotoxicity in the 
animals. The absence of these features in rats 
Table 3. Procoagulant effects of venoms from three pit vipers on mammalian fibrinogens
Venom H. hypnale C. rhodostoma C. purpureomaculatus
Source of 
fibrinogen
Clotting time* (s) 
(mean ± SEM)
Clotting time (s) 
(mean ± SEM)
Clotting time (s) 
(mean ± SEM)
Rabbit 18.3 ± 0.9 30.7 ± 1.2 Turbidity > 120 s
Horse 42.2 ± 1.0 40.1 ± 0.6 Turbidity > 60 s
Dog Turbidity** > 180 s Turbidity > 180 s Turbidity > 80 s
Goat 30.3 ± 0.9 33.0 ± 0.6 71.0 ± 0.6
Bovine 14.3 ± 0.3 11.3 ± 0.9 56.7 ± 0.7
Human 32.7 ± 0.7 28.4 ± 0.8 75.0 ± 0.6
* Clotting time is defined as the time (s) for apparent fibrin strands to appear in the mixture of venom and fibrinogen.** Turbidity 
refers to cloudiness appearing in the mixture of venom and fibrinogen, which may be interpreted as the formation of fibrin clots. 
Results are expressed as the mean ± SEM from three experiments.
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injected with a similar sublethal dose of H. 
hypnale venom suggested that the given dose of 
the venom does not cause direct nephrotoxicity. 
This is further demonstrated by light microscopic 
examination of histological cuts from the kidney 
(data not shown) and other vital organs (heart, 
lung, liver, spleen and diaphragm) of rats injected 
with the sublethal dose of H. hypnale venom, where 
all tissues appeared histologically intact. Thus, a 
tentative explanation of nephropathy observed 
in some of the victims (11, 66) is that the kidney 
damage is likely the result of complications from 
Figure 2. Time course of thrombin-like enzyme activity of three different crotalid venoms on fibrinogens 
from several mammals (A: cow; B: goat; C: horse; D: rabbit; E: human; F: dog). The slope (gradient) for 
each curve is calculated from the steepest upward portion of the graph representing the maximal 
clotting rate expressed as absorbance/minute. Absorbance reflects the change in mixture clarity, which is 
responsible for the formation of fibrin strands as well as their dissolution/degradation. “Clot” used in this 
discussion represents the formation of fibrins.  The crotalid species are: ─ H. hypnale; --- C. rhodostoma; ∙∙∙∙ C. 
purpureomaculatus. 
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the venom’s hematoxic effects mediated through 
its procoagulant and possibly fibrinolytic actions. 
This suggestion is in line with the view that the 
nephropathy was associated with disseminated 
intravascular coagulopathy (61).
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